CO [Global Cord Blood] 6-K: (Original Filing)

[Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020 1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million) Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($1]

By | 2019-08-28T03:48:44+00:00 August 27th, 2019|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Global Cord Blood] 6-K: Global Cord Blood Corporation Reports Financial Results for

[Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020 1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million) Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($1]

By | 2019-08-28T03:48:49+00:00 August 27th, 2019|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Global Cord Blood] 20-F/A: (Original Filing)

[FORM 20-F/A Amendment No. 1 o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albe]

By | 2019-08-15T04:05:30+00:00 August 14th, 2019|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Global Cord Blood] 20-F/A: FORM 20-F/A Amendment No. 1 o OR x

[FORM 20-F/A Amendment No. 1 o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albe]

By | 2019-08-15T04:05:34+00:00 August 14th, 2019|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Global Cord Blood] 20-F/A: (Original Filing)

[FORM 20-F/A Amendment No. 1 o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albe]

By | 2019-08-14T12:06:17+00:00 August 14th, 2019|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Global Cord Blood] 20-F/A: FORM 20-F/A Amendment No. 1 o OR x

[FORM 20-F/A Amendment No. 1 o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albe]

By | 2019-08-14T12:06:21+00:00 August 14th, 2019|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Global Cord Blood] 20-F: (Original Filing)

[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 ]

By | 2019-07-24T03:34:30+00:00 July 23rd, 2019|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Global Cord Blood] 20-F: FORM 20-F o OR x OR o For

[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: Global Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 ]

By | 2019-07-24T03:34:44+00:00 July 23rd, 2019|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Global Cord Blood] 6-K: (Original Filing)

[Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019 Added 22,194 New Subscribers in 4Q19 4Q19 Revenues Increased by 8.0% YoY to RMB251.7 Million ($37.5 Million) 4Q19 Operating Income Increased to RMB88.9 Million ($13.2 Million) Conference Call ]

By | 2019-06-19T03:33:14+00:00 June 18th, 2019|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Global Cord Blood] 6-K: Global Cord Blood Corporation Reports Financial Results for

[Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019 Added 22,194 New Subscribers in 4Q19 4Q19 Revenues Increased by 8.0% YoY to RMB251.7 Million ($37.5 Million) 4Q19 Operating Income Increased to RMB88.9 Million ($13.2 Million) Conference Call ]

By | 2019-06-19T03:33:21+00:00 June 18th, 2019|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar